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Previews
acids have now been incorporated into proteins usingYielding at Stop Codons:
this method, demonstrating that once a tRNA is aminoa-Expanding the Genetic Code cylated, the translation apparatus is reasonably promi-
scuous for different amino acids [13]. Different approaches
have also been undertaken in order to introduce the use-
fulness of aminoacylated suppressor tRNAs into livingCodon-specific incorporation of noncoded amino acids
cells. For example, aminoacylated suppressor tRNAsinto proteins can diversify the genetic code. Now, in
can be microinjected into Xenopus oocytes [14], andboth E. coli and S. cerevisiae, iterative rounds of selec-
direct uptake of aminoacylated tRNAs into mammaliantion can be used to isolate aminoacyl-tRNA synthe-
cell cultures has been demonstrated [15].tases that aminoacylate suppressor tRNAs with non-
Efforts have also been directed toward manipulatingcoded amino acids.
one or more aminoacyl-tRNA synthetase (AARS). The
The invariance of the genetic code is taken for granted. AARSs are the enzymes that are responsible for amino-
With the unusual exceptions of selenocysteine [1] and acylating tRNAs in vivo, with each AARS being highly
pyrrolysine [2, 3], biosynthetic proteins are restricted to specific only for its cognate amino acid [16]. Thus, if
the 20 encoded amino acids, and further diversity is an AARS could be mutagenized to recognize only a
only introduced by posttranslational modification or with suppressor tRNA and only a new noncoded amino acid,
cofactors. In most cases, the relationships between the then this mutant AARS/tRNA pair would be ideal for the
coded amino acids and their respective codons are also incorporation of unnatural amino acids in vivo. The one
invariant. Stops are stops and coding is coding—get caveat is that the new AARS must not aminoacylate any
the picture? Sadly, for scientists interested in decon- wild-type tRNAs, and the suppressor tRNA must not be
structing complex biological questions in vivo, nature a substrate for any wild-type AARSs. Several examples
didn’t select the most useful amino acids. In fact, hereti- of AARS/tRNA pairs that fit these “orthogonality” re-
cal as it may seem, as biochemical and biophysical quirements have now been reported [17–20].
tools, some of the encoded amino acids could even Recently, Schultz and coworkers have taken these
be considered boring and useless—at least to those efforts a step further by designing methods to select
interested in mapping the inner workings of the cell. novel orthogonal AARSs in vivo in both prokaryotic [7]
Thus, expanding the genetic code by controlled intro- and eukaryotic systems [6]. The elegance of these selec-
duction of a variety of different and useful amino acids tion strategies is that they are independent of the nature
into the proteome offers great biotechnological promise. of the desired noncoded amino acid. Of course, a new
Imagine the possibilities if one could design or choose AARS needs to be selected for each new amino acid;
any noncoded amino acid and incorporate it into any however, the selection schemes are based only on the
protein, at any position, in vivo, in any cell line. For presence or absence of the amino acid in the selection
example, nonhydrolyzable phosphonates could be used media, not on the nature of its side chain. In each case,
to characterize signal transduction pathways [4]. Fluo-
positive selection is used to identify mutated AARSs
rescent amino acids could illuminate protein trafficking
that can aminoacylate a suppressor tRNA at a levelpatterns or protein-protein interactions. One can also
sufficient to enable readthrough of a critical stop codonenvision applications for the incorporation of heavy
(conferring antibiotic resistance in E. coli [7] or enablingmetal derivatives, crosslinkers, and enzyme affinity la-
Gal4-mediated transcriptional activation in S. cerevisiaebels, among others [5]. Recent advances in noncoded
[6]). This selection is conducted in the presence of theamino acid incorporation in response to suppressor stop
unnatural amino acid of choice. Next, negative selectioncodons in vivo (Figure 1; and as reported by Schultz
is applied to weed out AARS variants that are not spe-and coworkers in this issue of Chemistry & Biology [6]
cific for the unnatural amino acid by removing this aminoand in a recent issue of the Journal of the American
acid from the media and selecting only those variantsChemical Society [7]) may soon make these applications
that can no longer read through stop codons. In E. coli,a reality.
cells were sorted based on a fluorescent signal [7],Early efforts to infiltrate the genetic code focused on
whereas in S. cerevisiae [6] cells were sorted based onconservative substitutions, like trifluoroleucine for Leu
sensitivity to 5-fluoroorotic acid (5-FOA). Both of these[8] and selenomethionine for Met [9]; these noncoded
reports used tyrosyl-tRNA synthetase (TyrRS) as a start-amino acids were incorporated throughout the pro-
ing point for the selection of a specific orthogonal AARS.teome. The first major breakthrough in the field came
For this reason, the current selection schemes havewith the discovery of suppressor tRNAs, combined with
been weighted toward hydrophobic amino acids. Impor-the development of methods to chemically aminoacy-
tantly, however, these strategies will surely prove appli-late these tRNAs with noncognate amino acids [10–12].
cable to other AARSs, opening the door for a wider arrayThese aminoacylated suppressor tRNAs participate in
of unnatural amino acid targets. In E. coli, the prokaryoticprotein translation by readthrough of specific stop co-
selection scheme was used to select a new AARS spe-dons, leading to incorporation of the unnatural amino
cific for p-aminophenylalanine: a p-aminophenylalanyl-acid into emerging peptide chains (Figure 1). Thus, the
tRNA synthetase, or pAFRS [7].ability to site specifically incorporate any chemically ac-
In a clever twist to their E. coli selection scheme,cessible amino acid into proteins, at least in vitro, was
achieved. More than 100 structurally diverse amino Schultz and coworkers have generated a fully indepen-
Chemistry & Biology
476
Figure 1. Codon Suppression as a General
Method for the Incorporation of Noncoded
Amino Acids into Biosynthetic Proteins
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